Sign In
Buy CRMD
$8.23
+0.0600 (+0.734%)
At Close: Jun 03, 2026
New York, New York--(Newsfile Corp. - July 23, 2021) - Bernstein Liebhard, a nationally acclaimed investor rights law firm, announces that a securities class action lawsuit has been filed on behalf of
Pomerantz Law Firm Announces the Filing of a Class Action Against CorMedix Inc. and Certain Officers - CRMD
09:03pm, Thursday, 22'nd Jul 2021
NEW YORK, July 22, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against CorMedix Inc. ("CorMedix" or the "Company") (NASDAQ: CRMD) and certain of its officer
Citius: Halt For Superiority On The Horizon
10:41am, Tuesday, 15'th Jun 2021
Citius: Halt For Superiority On The Horizon
CorMedix Inc. Completes Sale of $1.3 Million of NOL Tax Benefits Through The New Jersey Economic Development Authority Program
08:30am, Thursday, 10'th Jun 2021
BERKELEY HEIGHTS, N.J., June 10, 2021 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention an
CorMedix Inc. to Participate in Fireside Chat at the JMP Securities Life Sciences Conference
08:30am, Wednesday, 09'th Jun 2021
BERKELEY HEIGHTS, N.J., June 09, 2021 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention an
CorMedix Inc. to Present at the Jefferies Virtual Healthcare Conference
08:30am, Thursday, 27'th May 2021
BERKELEY HEIGHTS, N.J., May 27, 2021 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and
Why Bionano Genomics, CorMedix and Eloxx Are Moving Friday
10:27am, Friday, 14'th May 2021
Bionano Genomics, Inc. (NASDAQ: BNGO), CorMedix Inc. (NASDAQ: CRMD) and Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) are among the health care movers Friday. Bionano Moves On Q1 Results: Bionano reporte
CorMedix (CRMD) Stock: Over 24% Decrease Pre-Market Explanation
09:17am, Friday, 14'th May 2021
The stock price of CorMedix Inc. (NASDAQ: CRMD) decreased by over 24% pre-market. This is why it happened.
CorMedix Inc. (CRMD) CEO Khoso Baluch on Q1 2021 Results - Earnings Call Transcript
07:29pm, Thursday, 13'th May 2021
CorMedix Inc. (CRMD) CEO Khoso Baluch on Q1 2021 Results - Earnings Call Transcript
CorMedix (CRMD) Reports Q1 Loss, Tops Revenue Estimates
06:56pm, Thursday, 13'th May 2021
CorMedix (CRMD) delivered earnings and revenue surprises of -11.11% and 46.67%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
CorMedix Inc. Announces Appointment of Chief Commercial Officer
08:30am, Thursday, 13'th May 2021
Thomas Nusbickel to join CorMedix as Chief Commercial Officer; Brings significant experience in renal product launches and commercialization Thomas Nusbickel to join CorMedix as Chief Commercial Offic
CorMedix (CRMD) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
03:47pm, Monday, 03'rd May 2021
CorMedix (CRMD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CRMD Stock: Over 10% Decrease Intraday Explanation
11:53am, Wednesday, 14'th Apr 2021
The stock price of CorMedix Inc. (NASDAQ: CRMD) fell by over 10% during intraday trading. This is why it happened.
CorMedix Inc. to Present at the 20th Annual Needham Virtual Healthcare Conference
08:30am, Wednesday, 07'th Apr 2021
BERKELEY HEIGHTS, N.J., April 07, 2021 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention a
CorMedix (CRMD) Reports Q4 Loss, Lags Revenue Estimates
06:23pm, Tuesday, 30'th Mar 2021
CorMedix (CRMD) delivered earnings and revenue surprises of 17.39% and -11.11%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
